Wyzga Michael S

Wyzga Michael S is listed in filings as Director at Mereo BioPharma Group plc. This profile follows SEC Form 4 activity through Feb 27, 2026, including 9 public disclosures. Recent filings connect the profile to Mereo BioPharma Group plc (MREO), X4 Pharmaceuticals, Inc. (XFOR), and Tvardi Therapeutics, Inc. (TVRD). The current snapshot covers public activity from Jun 11, 2024 to Feb 27, 2026. Reported amounts are shown as $25.7K to $204.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.